$6.9B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | GH Guardant Health Inc | 3.4M | +1.6% | $509M | 7.4% |
| 2 | IMVT Immunovant Inc | 9.3M | −19.0% | $360M | 5.2% |
| 3 | GPCR Structure Therapeutics Inc | 4.7M | +10.8% | $254M | 3.7% |
| 4 | PCVX Vaxcyte Inc | 4.3M | +0.0% | $250M | 3.6% |
| 5 | ALNY Alnylam Pharmaceuticals Inc | 825,000 | — | $248M | 3.6% |
| 6 | MANE Veradermics Inc | 2.0M | +300.0% | $246M | 3.6% |
| 7 | TARS Tarsus Pharmaceuticals Inc | 3.7M | +1.9% | $231M | 3.4% |
| 8 | NUVALENT INC Nuvalent Inc | 1.8M | +29.6% | $220M | 3.2% |
| 9 | ALKS Alkermes Plc | 4.0M | +11.4% | $210M | 3.1% |
| 10 | OCUL Ocular Therapeutix Inc | 19.7M | +0.0% | $193M | 2.8% |
| 11 | BMRN Biomarin Pharmaceutical Inc | 3.3M | +187.6% | $189M | 2.8% |
| 12 | NRIX Nurix Therapeutics Inc | 7.7M | +21.9% | $188M | 2.7% |
| 13 | ORKA Oruka Therapeutics Inc | 1.9M | −5.3% | $183M | 2.7% |
| 14 | ALMS Alumis Inc | 6.3M | −6.3% | $179M | 2.6% |
| 15 | IONS Ionis Pharmaceuticals Inc | 2.2M | +12.8% | $174M | 2.5% |
| 16 | CMPS Compass Pathways Plc | 12.2M | +0.0% | $172M | 2.5% |
| 17 | VERA Vera Therapeutics Inc | 4.0M | −2.6% | $172M | 2.5% |
| 18 | AXSM Axsome Therapeutics Inc. | 700,000 | −36.4% | $171M | 2.5% |
| 19 | GMAB Genmab A/S | 5.7M | +54.2% | $155M | 2.3% |
| 20 | MLTX Moonlake Immunotherapeutics | 7.0M | +9.2% | $136M | 2.0% |
| 21 | COAG Hemab Therapeutics Hldgs Inc | 3.6M | — | $132M | 1.9% |
| 22 | TNGX Tango Therapeutics Inc | 4.2M | +52.7% | $131M | 1.9% |
| 23 | DFTX Definium Therapeutics Inc | 2.8M | −8.3% | $129M | 1.9% |
| 24 | GRAL Grail Inc | 1.8M | +6.5% | $125M | 1.8% |
| 25 | BCAX Bicara Therapeutics Inc | 4.1M | +0.9% | $122M | 1.8% |
| 26 | MAZE Maze Therapeutics Inc | 3.7M | +7.3% | $111M | 1.6% |
| 27 | CLDX Celldex Therapeutics Inc New | 2.9M | +128.9% | $109M | 1.6% |
| 28 | LBRX Lb Pharmaceuticals Inc | 3.4M | +0.0% | $109M | 1.6% |
| 29 | MBX Mbx Biosciences Inc | 1.7M | −37.2% | $96M | 1.4% |
| 30 | GHRS Gh Research Plc | 3.3M | — | $90M | 1.3% |
| 31 | COGT Cogent Biosciences Inc | 2.0M | +100.0% | $77M | 1.1% |
| 32 | ATAIBECKLEY INC Ataibeckley Inc | 14.4M | +20.1% | $76M | 1.1% |
| 33 | UTHR United Therapeutics Corp Del | 123,616 | — | $67M | 1.0% |
| 34 | AVTX Avalo Therapeutics Inc | 3.6M | — | $67M | 1.0% |
| 35 | VRDN Viridian Therapeutics Inc | 3.6M | +157.7% | $66M | 1.0% |
| 36 | CYTK Cytokinetics Inc | 700,000 | −49.1% | $60M | 0.9% |
| 37 | ALT Altimmune Inc | 19.2M | — | $59M | 0.9% |
| 38 | PSNL Personalis Inc | 4.0M | +33.3% | $54M | 0.8% |
| 39 | ACRS Aclaris Therapeutics Inc | 9.3M | +0.0% | $49M | 0.7% |
| 40 | CRMD Cormedix Inc | 6.3M | +0.0% | $49M | 0.7% |
| 41 | WGS Genedx Holdings Corp | 700,000 | — | $48M | 0.7% |
| 42 | HROW Harrow Inc | 969,000 | — | $41M | 0.6% |
| 43 | CRVS Corvus Pharmaceuticals Inc | 2.5M | +0.0% | $37M | 0.5% |
| 44 | SLDB Solid Biosciences Inc | 3.6M | +0.0% | $36M | 0.5% |
| 45 | BEAM Beam Therapeutics Inc | 1.0M | +21.8% | $34M | 0.5% |
| 46 | DYN Dyne Therapeutics Inc | 1.5M | −25.0% | $33M | 0.5% |
| 47 | IMMX Immix Biopharma Inc | 2.8M | — | $29M | 0.4% |
| 48 | XFOR X4 Pharmaceuticals Inc | 5.9M | −7.3% | $27M | 0.4% |
| 49 | STTK Shattuck Labs Inc | 3.7M | — | $26M | 0.4% |
| 50 | MNKD Mannkind Corp | 6.0M | — | $26M | 0.4% |